March 22, 2012 /

AVI Clinical Trial Update (March 2012)

Parent Project Muscular Dystrophy by: Parent Project Muscular Dystrophy

AVI Clinical Trial Update (March 2012)

Parent Project Muscular Dystrophy’s AVI webinar covers a pre-data update on AVI BioPharma’s Phase IIb study evaluating eteplirsen for the treatment of Duchenne patients with mutations amenable to exon-51 skipping. The webinar was lead by Chris Garabedian, the CEO of AVI BioPharma.

Research & Clinical Trial Webinars,
Webinars

Join Our Mailing List

BBB Accredited Charity logoCharity Navigator Four Star Charity logoNational Health Council Standards of Excellence Certification Program logo